Compounds > imipenem, anhydrous
Page last updated: 2024-08-26

imipenem, anhydrous and Hematologic Malignancies

imipenem, anhydrous has been researched along with Hematologic Malignancies in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's7 (70.00)29.6817
2010's1 (10.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Buclin, T; Calandra, T; Csajka, C; Lamoth, F; Marchetti, O; Pascual, A1
Hu, X; Huang, H; Li, W; Zhang, D; Zhang, X1
Huang, W; Jing, Y; Li, J; Wang, Q; Yu, L; Yuan, L; Zhao, X; Zhou, D1
Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L1
Jongman, LR; Lugtenburg, PJ; Rijnders, BJ; Slobbe, L; Waal, Lv1
Bellabas, H; Defez, C; Fabbro-Peray, P; Jourdan, E; Jourdan, J; Richard, B; Sotto, A; Topart, D1
Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P1
Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N1
Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC1
Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G1

Trials

2 trial(s) available for imipenem, anhydrous and Hematologic Malignancies

ArticleYear
Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
    Clinical transplantation, 2016, Volume: 30, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Febrile Neutropenia; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Risk Factors

2016
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome

2004

Other Studies

8 other study(ies) available for imipenem, anhydrous and Hematologic Malignancies

ArticleYear
Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Female; Glomerular Filtration Rate; Guidelines as Topic; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Models, Biological; Neutropenia; Young Adult

2009
Accurate Identification and Virulence Detection of Aeromonas: a Single-Center Retrospective Study on the Clinical Features and Outcomes Associated with Aeromonas Bacteremia in Southwestern China.
    Japanese journal of infectious diseases, 2023, Jan-24, Volume: 76, Issue:1

    Topics: Aeromonas; Anti-Bacterial Agents; Bacteremia; Hematologic Neoplasms; Humans; Imipenem; Retrospective Studies; Virulence

2023
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin

2009
Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
    European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Colistin; Drug Therapy, Combination; Female; Fever of Unknown Origin; Fluconazole; Fluoroquinolones; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Withholding Treatment; Young Adult

2009
Evaluation of imipenem 1.5 g daily in febrile patients with short duration neutropenia after chemotherapy for non-leukemic hematologic malignancies and solid tumors: personal experience and review of the literature.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Escherichia coli; Female; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Retrospective Studies; Time Factors; Treatment Outcome

2003
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    JPMA. The Journal of the Pakistan Medical Association, 2004, Volume: 54, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin

2004
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2006, Volume: 39, Issue:2

    Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors

2006
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
    Pathologie-biologie, 1998, Volume: 46, Issue:6

    Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin

1998